{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:31:26Z","timestamp":1775734286358,"version":"3.50.1"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T00:00:00Z","timestamp":1217808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2393-8-33","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T06:14:55Z","timestamp":1217916895000},"source":"Crossref","is-referenced-by-count":95,"title":["Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysis"],"prefix":"10.1186","volume":"8","author":[{"given":"Rachel K","family":"Morris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeltsje S","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes","family":"Langejans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C","family":"Robson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerben","family":"ter Riet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben W","family":"Mol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris AM","family":"van der Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid S","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,4]]},"reference":[{"issue":"6","key":"177_CR1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1542\/peds.99.4.585","volume":"99","author":"WW Hay Jr","year":"1997","unstructured":"Hay WW, Catz CS, Grave GD, Yaffe SJ: Workshop summary: fetal growth: its regulation and disorders. Pediatrics. 1997, 99 (6): 585-591.","journal-title":"Pediatrics"},{"issue":"16","key":"177_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","volume":"340","author":"DJ McIntire","year":"1999","unstructured":"McIntire DJ, Bloom SL, Casey BM, Levenko KJ: Birth weight in relation to morbidity and mortality among newborn infants. N Eng J Med. 1999, 340 (16): 1234-1238. 10.1056\/NEJM199904223401603.","journal-title":"N Eng J Med"},{"issue":"7","key":"177_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1471-0528.1989.tb03317.x","volume":"96","author":"DJ Taylor","year":"1989","unstructured":"Taylor DJ, Howie PW: Fetal growth achievement and neurodevelopmental disability. Br J Obstet Gynaecol. 1989, 96 (7): 789-794.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4 Pt 1","key":"177_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00005","volume":"130","author":"J Rich-Edwards","year":"1999","unstructured":"Rich-Edwards J, Colditz G, Stampfer M, Willett W, Gillman M, Hennekens C: Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med. 1999, 130 (4 Pt 1): 278-284.","journal-title":"Ann Intern Med"},{"issue":"446","key":"177_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2004.tb00236.x","volume":"93","author":"DJ Barker","year":"2004","unstructured":"Barker DJ: The developmental origins of chromic adult disease. Acta Paediatr Suppl. 2004, 93 (446): 26-33.","journal-title":"Acta Paediatr Suppl"},{"issue":"15","key":"177_CR6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJMoa025273","volume":"349","author":"R Wapner","year":"2003","unstructured":"Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K: First trimester screening for trisomies 21 and 18. N Eng J Med. 2003, 349 (15): 1405-1413. 10.1056\/NEJMoa025273.","journal-title":"N Eng J Med"},{"issue":"4","key":"177_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0002-9378(99)70334-0","volume":"181","author":"Y Yaron","year":"1999","unstructured":"Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI: Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999, 181 (4): 968-974. 10.1016\/S0002-9378(99)70334-0.","journal-title":"Am J Obstet Gynecol"},{"issue":"5\u20136","key":"177_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/plac.2000.0540","volume":"21","author":"J Aquilina","year":"2000","unstructured":"Aquilina J, Maplethorpe R, Ellis P, Harrington K: Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia. Placenta. 2000, 21 (5\u20136): 487-492. 10.1053\/plac.2000.0540.","journal-title":"Placenta"},{"issue":"10","key":"177_CR9","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","volume":"107","author":"CY Ong","year":"2000","unstructured":"Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH: First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG. 2000, 107 (10): 1265-1270. 10.1111\/j.1471-0528.2000.tb11618.x.","journal-title":"BJOG"},{"issue":"2","key":"177_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W","volume":"18","author":"LP Morssink","year":"1998","unstructured":"Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beckhuis JR, De Wolf BT, Montingh A: Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn. 1998, 18 (2): 147-152. 10.1002\/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W.","journal-title":"Prenat Diagn"},{"issue":"9575","key":"177_CR11","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","volume":"369","author":"L Askie","year":"2007","unstructured":"Askie L, Duley L, Henderson-Smart D, Stewart L: Antiplatelet agents for preventing pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007, 369 (9575): 1791-1798. 10.1016\/S0140-6736(07)60712-0.","journal-title":"Lancet"},{"key":"177_CR12","volume-title":"Guideline No 31 Nov 2002","author":"A Coomarasamy","year":"2003","unstructured":"Coomarasamy A, Frisk NM, Gee H, Robson SC: The Investigation and Management of the Small for Gestational Age Fetus. Guideline No 31 Nov 2002. 2003, RCOG, London"},{"key":"177_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2393-6-29","volume":"6","author":"JS Cnossen","year":"2006","unstructured":"Cnossen JS, Post van der JAM, Mol BW, Khan KS, Meads C, der Riet G: Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. BMC Pregnancy and Childbirth. 2006, 6: 29-10.1186\/1471-2393-6-29.","journal-title":"BMC Pregnancy and Childbirth"},{"key":"177_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2393-7-3","volume":"7","author":"RK Morris","year":"2007","unstructured":"Morris RK, Khan K, Coomarasamy A, Robson S, Kleijnen J: The value of prediciting fetal growth restriction and compromise of its wellbeing: Systematic quantitative overviews (meta-analysis) of test accuracy literature. BMC Pregnancy and Childbirth. 2007, 7: 3-10.1186\/1471-2393-7-3.","journal-title":"BMC Pregnancy and Childbirth"},{"key":"177_CR15","volume-title":"Recommended methods","author":"Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests","year":"1996","unstructured":"Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests: Recommended methods. 1996"},{"issue":"7305","key":"177_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","volume":"323","author":"J Deeks","year":"2001","unstructured":"Deeks J: Systematic reviews in health care: systematic reviews of diagnostic and screening tests. BMJ. 2001, 323 (7305): 157-162. 10.1136\/bmj.323.7305.157.","journal-title":"BMJ"},{"issue":"8","key":"177_CR17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-120-8-199404150-00008","volume":"120","author":"L Irwig","year":"1994","unstructured":"Irwig L, Tosteson AN, Gatsonis C, Low J, Colditz G, Chalmers TC, Mosteller F: Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994, 120 (8): 667-676.","journal-title":"Ann Intern Med"},{"issue":"1","key":"177_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0301-2115(00)00463-2","volume":"95","author":"KS Khan","year":"2001","unstructured":"Khan KS, Dinnes J, Kleijnen J: Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol. 2001, 95 (1): 6-11. 10.1016\/S0301-2115(00)00463-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"177_CR19","doi-asserted-by":"publisher","first-page":"IX","DOI":"10.1081\/PRG-100104165","volume":"20","author":"MA Brown","year":"2001","unstructured":"Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001, 20 (1): IX-XIV. 10.1081\/PRG-100104165.","journal-title":"Hypertens Pregnancy"},{"issue":"8","key":"177_CR20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1471-0528.2005.00656.x","volume":"112","author":"LM McCowan","year":"2005","unstructured":"McCowan LM, Harding JE, Stewart AW: Customized birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG. 2005, 112 (8): 1026-1033.","journal-title":"BJOG"},{"issue":"6","key":"177_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1471-0528.2002.01367.x","volume":"109","author":"P Owen","year":"2002","unstructured":"Owen P, Farrell T, Hardwick JC, Khan KS: Relationship between customised birthweight centiles and neonatal anthropometric features of growth restriction. BJOG. 2002, 109 (6): 658-662. 10.1111\/j.1471-0528.2002.01367.x.","journal-title":"BJOG"},{"issue":"1","key":"177_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1479-828X.1991.tb02755.x","volume":"31","author":"RA Fay","year":"1991","unstructured":"Fay RA, Dey PL, Saadie CM, Buhl JA, Gebski VJ: Ponderal index: a better definition of the 'at risk' group with intrauterine growth problems than birth-weight for gestational age in term infants. Aust N Z J Obstet Gynaecol. 1991, 31 (1): 17-19. 10.1111\/j.1479-828X.1991.tb02755.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"177_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1515\/JPM.2004.120","volume":"32","author":"H Tamim","year":"2004","unstructured":"Tamim H, Beydoun H, Itani M, Khogali M, Chokr I, Yunis KA, The National Collaborative Perinatal Neonatal Network: Predicting neonatal outcomes: birthweight, body mass index or ponderal index?. J Perinat Med. 2004, 32 (6): 509-513. 10.1515\/JPM.2004.120.","journal-title":"J Perinat Med"},{"issue":"2","key":"177_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0378-3782(85)90104-5","volume":"11","author":"J Excler","year":"1985","unstructured":"Excler J, Sann L, Lasne Y, Picard J: Anthropometric assessment of nutritional status in newborn infants. Discriminative value of mid arm circumference and of skinfold thickness. Early Hum Dev. 1985, 11 (2): 169-178. 10.1016\/0378-3782(85)90104-5.","journal-title":"Early Hum Dev"},{"key":"177_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-3-25","volume":"3","author":"P Whiting","year":"2003","unstructured":"Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003, 3: 25-10.1186\/1471-2288-3-25.","journal-title":"BMC Med Res Methodol"},{"key":"177_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-6-9","volume":"6","author":"PF Whiting","year":"2006","unstructured":"Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J: Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006, 6: 9-10.1186\/1471-2288-6-9.","journal-title":"BMC Med Res Methodol"},{"issue":"7379","key":"177_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/bmj.326.7379.41","volume":"326","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Orwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, the STARD Group: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003, 326 (7379): 41-44. 10.1136\/bmj.326.7379.41.","journal-title":"BMJ"},{"issue":"11","key":"177_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","volume":"282","author":"JG Lijmer","year":"1999","unstructured":"Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, Meulen van der JH, Bossuyt PM: Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999, 282 (11): 1061-1066. 10.1001\/jama.282.11.1061.","journal-title":"JAMA"},{"issue":"4","key":"177_CR29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.050090","volume":"174","author":"AW Rutjes","year":"2006","unstructured":"Rutjes AW, Reitsma J, Di N, Smidt N, van Rijn J, Bossuyt PM: Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006, 174 (4): 469-476.","journal-title":"CMAJ"},{"issue":"25","key":"177_CR30","doi-asserted-by":"crossref","first-page":"iii, 1","DOI":"10.3310\/hta8250","volume":"8","author":"P Whiting","year":"2004","unstructured":"Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J: Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004, 8 (25): iii, 1-234.","journal-title":"Health Technol Assess"},{"issue":"1","key":"177_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6963-2-4","volume":"2","author":"H Honest","year":"2002","unstructured":"Honest H, Khan KS: Reporting of measures of accuracy in systematic reviews of diagnostic literature. BMC Health Serv Resh. 2002, 2 (1): 4-10.1186\/1472-6963-2-4.","journal-title":"BMC Health Serv Resh"},{"issue":"9","key":"177_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.271.9.703","volume":"271","author":"R Jaeschke","year":"1994","unstructured":"Jaeschke R, Guyatt GH, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994, 271 (9): 703-707. 10.1001\/jama.271.9.703.","journal-title":"JAMA"},{"issue":"10","key":"177_CR33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1471-0528.1997.tb10942.x","volume":"104","author":"K Khan","year":"1997","unstructured":"Khan K, Chien PF: Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions. Br J Obstet Gynaecol. 1997, 104 (10): 1173-1179.","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"177_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00006254-199702000-00023","volume":"52","author":"M Gulmezoglu","year":"1997","unstructured":"Gulmezoglu M, de OM, Villar J: Effectiveness of interventions to prevent or treat impaired fetal growth. Obstet Gynecol Surv. 1997, 52 (2): 139-149. 10.1097\/00006254-199702000-00023.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"177_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/uog.29","volume":"21","author":"P Florio","year":"2003","unstructured":"Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F: The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2003, 21 (2): 165-169. 10.1002\/uog.29.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"177_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0029-7844(02)02640-6","volume":"101","author":"GG Zeeman","year":"2003","unstructured":"Zeeman GG, Alexander JM, McIntire DD, Byrd W, Leveno KJ: Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Obstet Gynecol. 2003, 101 (2): 232-236. 10.1016\/S0029-7844(02)02640-6.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"177_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000065384","volume":"17","author":"Y Yaron","year":"2002","unstructured":"Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A: First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther. 2002, 17 (6): 352-356. 10.1159\/000065384.","journal-title":"Fetal Diagn Ther"},{"issue":"9","key":"177_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/pd.407","volume":"22","author":"Y Yaron","year":"2002","unstructured":"Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A: Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn. 2002, 22 (9): 778-782. 10.1002\/pd.407.","journal-title":"Prenat Diagn"},{"issue":"(4)7","key":"177_CR39","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1210\/jc.87.4.1762","volume":"8","author":"GC Smith","year":"2002","unstructured":"Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM: Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002, 8 ((4)7): 1762-1767. 10.1210\/jc.87.4.1762.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"177_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1469-0705.2001.00382.x","volume":"17","author":"J Aquilina","year":"2001","unstructured":"Aquilina J, Thompson O, Thilaganathan B, Harrington K: Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol. 2001, 17 (16): 477-484. 10.1046\/j.1469-0705.2001.00382.x.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"177_CR41","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/1097-0223(200009)20:9<738::AID-PD917>3.0.CO;2-R","volume":"20","author":"LC Lee","year":"2000","unstructured":"Lee LC, Sheu BC, Shau WY, Liu DM, Lai TJ, Lee YH, Huang SC: Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia. Prenat Diagn. 2000, 20 (9): 738-743. 10.1002\/1097-0223(200009)20:9<738::AID-PD917>3.0.CO;2-R.","journal-title":"Prenat Diagn"},{"issue":"8","key":"177_CR42","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/humrep\/15.8.1813","volume":"15","author":"TN Leung","year":"2000","unstructured":"Leung TN, Chung TK, Madsen G, Lam CWK, Lam PKW, Walters WAW, Smith R: Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia. Hum Reprod. 2000, 15 (8): 1813-1818. 10.1093\/humrep\/15.8.1813.","journal-title":"Hum Reprod"},{"issue":"7","key":"177_CR43","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/humrep\/15.7.1640","volume":"15","author":"S Muttukrishna","year":"2000","unstructured":"Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W, Groome N, Redman CWG: Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod. 2000, 15 (7): 1640-1645. 10.1093\/humrep\/15.7.1640.","journal-title":"Hum Reprod"},{"issue":"3","key":"177_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1071-5576(00)00050-2","volume":"7","author":"GM Lambert-Messerlian","year":"2000","unstructured":"Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pelzani I, Maybruck WM, Hogge WA, Hanley-Yanez K, Roberts JM: Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig. 2000, 7 (3): 170-174. 10.1016\/S1071-5576(00)00050-2.","journal-title":"J Soc Gynecol Investig"},{"issue":"6","key":"177_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1471-0528.2000.tb13343.x","volume":"107","author":"NJ Sebire","year":"2000","unstructured":"Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH: Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia. BJOG. 2000, 107 (6): 795-797. 10.1111\/j.1471-0528.2000.tb13343.x.","journal-title":"BJOG"},{"issue":"3","key":"177_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1067\/mob.2000.103890","volume":"182","author":"DM Stamilio","year":"2000","unstructured":"Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA: Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?. Am J Obstet Gynecol. 2000, 182 (3): 589-594. 10.1067\/mob.2000.103890.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"177_CR47","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1093\/humrep\/14.11.2872","volume":"14","author":"B Haddad","year":"1999","unstructured":"Haddad B, Abirached F, Louis-Sylvestre C, Le Blond J, Paniel BJ, Zorn JR: Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Hum Reprod. 1999, 14 (11): 2872-2875. 10.1093\/humrep\/14.11.2872.","journal-title":"Hum Reprod"},{"issue":"2","key":"177_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/(SICI)1097-0223(199902)19:2<122::AID-PD491>3.0.CO;2-R","volume":"19","author":"R Raty","year":"1999","unstructured":"Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U: Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn. 1999, 19 (2): 122-127. 10.1002\/(SICI)1097-0223(199902)19:2<122::AID-PD491>3.0.CO;2-R.","journal-title":"Prenat Diagn"},{"issue":"6","key":"177_CR49","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0029-7844(98)00112-4","volume":"91","author":"AM Pouta","year":"1998","unstructured":"Pouta AM, Hartikainen AL, Vuolteenaho OJ, Ruokonen AO, Laatikainen TJ: Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia. Obstet Gynecol. 1998, 91 (6): 940-944. 10.1016\/S0029-7844(98)00112-4.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1034\/j.1600-0412.1998.770404.x","volume":"77","author":"M Luckas","year":"1998","unstructured":"Luckas M, Hawe J, Meekins J, Neilson J, Walkinshaw S: Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia. Acta Obstet Gynecol Scand. 1998, 77 (4): 381-384. 10.1034\/j.1600-0412.1998.770404.x.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"177_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0020-7292(96)02830-5","volume":"56","author":"LS Onderoglu","year":"1997","unstructured":"Onderoglu LS, Kabukcu A: Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynaecol Obstet. 1997, 56 (3): 245-249. 10.1016\/S0020-7292(96)02830-5.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"177_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0002-9378(97)70512-X","volume":"176","author":"AM Ashour","year":"1997","unstructured":"Ashour AM, Lieberman ES, Haug LE, Repke JT: The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol. 1997, 176 (2): 438-442. 10.1016\/S0002-9378(97)70512-X.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"177_CR53","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/(SICI)1097-0223(199612)16:12<1129::AID-PD9>3.0.CO;2-I","volume":"16","author":"E Jauniaux","year":"1996","unstructured":"Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S: Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Prenat Diagn. 1996, 16 (12): 1129-1135. 10.1002\/(SICI)1097-0223(199612)16:12<1129::AID-PD9>3.0.CO;2-I.","journal-title":"Prenat Diagn"},{"issue":"5","key":"177_CR54","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0029-7844(96)00310-9","volume":"88","author":"DK Waller","year":"1996","unstructured":"Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB: The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol. 1996, 88 (5): 816-822. 10.1016\/0029-7844(96)00310-9.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"177_CR55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2007-994384","volume":"13","author":"S Heinonen","year":"1996","unstructured":"Heinonen S, Ryynanen M, Kirkinen P, Saarikoski S: Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. Am J Perinatol. 1996, 13 (7): 437-441.","journal-title":"Am J Perinatol"},{"issue":"1","key":"177_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9378(96)70247-8","volume":"175","author":"F Muller","year":"1996","unstructured":"Muller F, Savey L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, Giraudet P: Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol. 1996, 175 (1): 37-40. 10.1016\/S0002-9378(96)70247-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"177_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0029-7844(95)00377-0","volume":"87","author":"KD Wenstrom","year":"1996","unstructured":"Wenstrom KD, Owen J, Davis RO, Brumfield CG: Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol. 1996, 87 (2): 213-216. 10.1016\/0029-7844(95)00377-0.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000188939","volume":"72","author":"P Vaillant","year":"1996","unstructured":"Vaillant P, David E, Constant I, Athmani B, Devulder G, Fievet P, Gondry J, Boulanger JC, Fardelone P, Fournier A: Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron. 1996, 72 (4): 557-563.","journal-title":"Nephron"},{"issue":"6","key":"177_CR59","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/0002-9378(95)90420-4","volume":"173","author":"JL Simpson","year":"1995","unstructured":"Simpson JL, Palomaki GE, Mercer B, Haddow JE, Andersen R, Sibai B, Elias S: Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol. 1995, 173 (6): 1742-1748. 10.1016\/0002-9378(95)90420-4.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"177_CR60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9378(89)90501-2","volume":"161","author":"A Milunsky","year":"1989","unstructured":"Milunsky A, Jick SS, Bruell CL, Maclaughlin DS, Tsung YK, Jick H, Rothman KJ, Willett W: Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol. 1989, 161 (2): 291-297.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"177_CR61","first-page":"257","volume":"37","author":"EL Capeless","year":"1992","unstructured":"Capeless EL, Kelleher PC, Walters CP: Elevated maternal serum alpha-fetoprotein levels and maternal risk factors: Their association with pregnancy complications. J Reprod Med. 1992, 37 (3): 257-260.","journal-title":"J Reprod Med"},{"issue":"5 Pt 1","key":"177_CR62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0029-7844(97)00088-4","volume":"89","author":"LP Morssink","year":"1997","unstructured":"Morssink LP, Heringa MP, Beekhuis JR, De Wolf BT, Mantingh A: The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol. 1997, 89 (5 Pt 1): 666-670. 10.1016\/S0029-7844(97)00088-4.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"177_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1600-0412.2004.00140.x","volume":"83","author":"EM Roes","year":"2004","unstructured":"Roes EM, Gaytant MA, Thomas CM, Raijmakers MTM, Zusterzeel PLM, Peters WHM, Steegers EAP: First trimester inhibin-A concentrations and later development of preeclampsia. Acta Obstet Gynecol Scand. 2004, 83 (1): 117-10.1111\/j.1600-0412.2004.00140.x.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"177_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000081369","volume":"20","author":"F Audibert","year":"2005","unstructured":"Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R: Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther. 2005, 20 (1): 48-53. 10.1159\/000081369.","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"177_CR65","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000080159","volume":"19","author":"B Brajenovic-Milic","year":"2004","unstructured":"Brajenovic-Milic B, Tislaric D, Zuvic-Butorac M, Back J, Petrovic O, Ristic S, Mimica M, Kapovic M: Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes. Fetal Diagn Ther. 2004, 19 (6): 483-487. 10.1159\/000080159.","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"177_CR66","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidavar J, D'Alton ME: First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004, 191 (4): 1446-1451. 10.1016\/j.ajog.2004.06.052.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"177_CR67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","volume":"106","author":"L Dugoff","year":"2005","unstructured":"Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, FASTER Trial Research Consortium: Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005, 106 (2): 260-267.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1479-828X.2005.00412.x","volume":"45","author":"E Ay","year":"2005","unstructured":"Ay E, Kavak ZN, Elter K, Gokaslan H, Pekin T: Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Aust N Z J Obstet Gynaecol. 2005, 45 (4): 283-288. 10.1111\/j.1479-828X.2005.00412.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"177_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/10641950500280995","volume":"24","author":"R Hershkovitz","year":"2005","unstructured":"Hershkovitz R, De SM, Kingdom J: Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy. 2005, 24 (3): 273-280. 10.1080\/10641950500280995.","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"177_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijgo.2005.10.002","volume":"92","author":"J Roiz-Hernandez","year":"2006","unstructured":"Roiz-Hernandez J, de JC-M, Fernandez-Mejia M: Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre-eclampsia. Int J Gynaecol Obstet. 2006, 92 (2): 101-105. 10.1016\/j.ijgo.2005.10.002.","journal-title":"Int J Gynaecol Obstet"},{"issue":"10","key":"177_CR71","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/pd.1251","volume":"25","author":"K Spencer","year":"2005","unstructured":"Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH: Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005, 25 (10): 949-953. 10.1002\/pd.1251.","journal-title":"Prenat Diagn"},{"issue":"6","key":"177_CR72","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/uog.2676","volume":"27","author":"K Spencer","year":"2006","unstructured":"Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH: Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol. 2006, 27 (6): 559-564. 10.1002\/uog.2676.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"177_CR73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/pd.1459","volume":"26","author":"NJ Wald","year":"2006","unstructured":"Wald NJ, Morris JK, Ibison J, Wu T, George LM: Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Prenat Diagn. 2006, 26 (6): 559-564. 10.1002\/pd.1459.","journal-title":"Prenat Diagn"},{"issue":"2","key":"177_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/uog.3881","volume":"29","author":"A Pilalis","year":"2007","unstructured":"Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A: Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11\u201314 weeks' gestation. Ultrasound Obstet Gynecol. 2007, 29 (2): 135-140. 10.1002\/uog.3881.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"177_CR75","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0029-7844(97)00677-7","volume":"91","author":"TD Kowalczyk","year":"1998","unstructured":"Kowalczyk TD, Cabaniss ML, Cusmano L: Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome. Obstet Gynecol. 1998, 91 (3): 396-400. 10.1016\/S0029-7844(97)00677-7.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"177_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0020-7292(95)02633-9","volume":"53","author":"AA Akinbiyi","year":"1996","unstructured":"Akinbiyi AA: Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk. Int J Gynaecol Obstet. 1996, 53 (1): 17-21. 10.1016\/0020-7292(95)02633-9.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"177_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0029-7844(95)00390-8","volume":"87","author":"PA Benn","year":"1996","unstructured":"Benn PA, Horne D, Briganti S, Rodis JF, Clive JM: Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol. 1996, 87 (2): 217-222. 10.1016\/0029-7844(95)00390-8.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"177_CR78","first-page":"71","volume":"79","author":"IM Bernstein","year":"1992","unstructured":"Bernstein IM, Barth RA, Miller R, Capeless EL: Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies. Obstet Gynecol. 1992, 79 (1): 71-74.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"177_CR79","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1469-0705.1992.02050333.x","volume":"2","author":"S Bewley","year":"1992","unstructured":"Bewley S, Chard T, Grudzinskas G, Cooper D, Campbell S: Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing. Ultrasound Obstet Gynecol. 1992, 2 (5): 333-337. 10.1046\/j.1469-0705.1992.02050333.x.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"177_CR80","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/00016349409072500","volume":"73","author":"DL Bloxam","year":"1994","unstructured":"Bloxam DL, Williams NR, Waskett RJ, Stewart SG: Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alpha-fetoprotein in normal human pregnancies. [Review] [49 refs]. Acta Obstet Gynecol Scand. 1994, 73 (10): 758-764. 10.3109\/00016349409072500.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"177_CR81","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/0002-9378(94)90028-0","volume":"171","author":"WF Brazerol","year":"1994","unstructured":"Brazerol WF, Grover S, Donnenfeld AE: Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population. Am J Obstet Gynecol. 1994, 171 (4): 1030-1035.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"177_CR82","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000293694","volume":"26","author":"K Bremme","year":"1988","unstructured":"Bremme K, Eneroth P, Nilsson B, Marsk L, Hagenfeldt L: Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up. Gynecol Obstet Invest. 1988, 26 (3): 191-205.","journal-title":"Gynecol Obstet Invest"},{"issue":"7","key":"177_CR83","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-0528.1980.tb05008.x","volume":"87","author":"DJ Brock","year":"1980","unstructured":"Brock DJ, Barron L, Raab GM: The potential of mid-trimester maternal plasma alpha-fetoprotein measurement in predicting infants of low birth weight. Br J Obstet Gynaecol. 1980, 87 (7): 582-585.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"177_CR84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/jpme.1984.12.3.127","volume":"12","author":"CM Buckland","year":"1984","unstructured":"Buckland CM, Thom H, Campbell AG: Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies. J Perinat Med. 1984, 12 (3): 127-132.","journal-title":"J Perinat Med"},{"issue":"5","key":"177_CR85","first-page":"709","volume":"72","author":"BK Burton","year":"1988","unstructured":"Burton BK: Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstetrics & Gynecology. 1988, 72 (5): 709-713.","journal-title":"Obstetrics & Gynecology"},{"issue":"8","key":"177_CR86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-994183","volume":"14","author":"SJ Chapman","year":"1997","unstructured":"Chapman SJ, Brumfield CG, Wenstrom KD, Dubard MB: Pregnancy outcomes following false-positive multiple marker screening tests. Am J Perinatol. 1997, 14 (8): 475-478.","journal-title":"Am J Perinatol"},{"issue":"1","key":"177_CR87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-0528.1986.tb07810.x","volume":"93","author":"T Chard","year":"1986","unstructured":"Chard T, Rice A, Kitau MJ, Hird V, Grudzinskas JG, Nysenbaum AM: Mid-trimester levels of alphafetoprotein in the screening of low birthweight. Br J Obstet Gynaecol. 1986, 93 (1): 36-38.","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"177_CR88","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1067\/mob.2002.125240","volume":"187","author":"D Chitayat","year":"2002","unstructured":"Chitayat D, Farrell SA, Huang T, Meier C, Wyatt PR, Summers AM: Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Am J Obstet Gynecol. 2002, 187 (3): 758-763. 10.1067\/mob.2002.125240.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"177_CR89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1515\/jpme.1997.25.6.476","volume":"25","author":"S Cho","year":"1997","unstructured":"Cho S, Durfee KK, Keel BA, Parks LH: Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening. J Perinat Med. 1997, 25 (6): 476-483.","journal-title":"J Perinat Med"},{"issue":"3","key":"177_CR90","first-page":"174","volume":"60","author":"MU Cox","year":"1995","unstructured":"Cox MU, Kingdom J, Whittle M, McNay M, Fleming J, Bowman A, Crossley J, Aitken D: [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results]. Rev Chil Obstet Ginecol. 1995, 60 (3): 174-180.","journal-title":"Rev Chil Obstet Ginecol"},{"issue":"5","key":"177_CR91","first-page":"327","volume":"41","author":"W Cusick","year":"1996","unstructured":"Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA: Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. J Reprod Med. 1996, 41 (5): 327-332.","journal-title":"J Reprod Med"},{"issue":"4","key":"177_CR92","first-page":"155","volume":"10","author":"MM Di","year":"1998","unstructured":"Di MM, Piazzi G, Ferrari A, Lotzniker M, Gerola O, Spinillo A: A simultaneous evaluation of second trimester serum AFP, hCG and unconjugated oestriol as predictors of small for gestational age births. Italian Journal of Gynaecology & Obstetrics. 1998, 10 (4): 155-159.","journal-title":"Italian Journal of Gynaecology & Obstetrics"},{"issue":"4","key":"177_CR93","first-page":"285","volume":"137","author":"TA Doran","year":"1987","unstructured":"Doran TA, Valentine GH, Wong PY, Wielgosz G, Benzie RJ, Soltan HC, Jenner MR, Morland PA, Montogomery RJ, Allen LC: Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project. CMAJ. 1987, 137 (4): 285-293.","journal-title":"CMAJ"},{"issue":"1","key":"177_CR94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/107155769400100111","volume":"1","author":"JS Dungan","year":"1994","unstructured":"Dungan JS, Shulman LP, Phillips OP, Simpson JL, Meyer NL, Grevengood C, Elias S: Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy. J Soc Gynecol Investig. 1994, 1 (1): 55-58.","journal-title":"J Soc Gynecol Investig"},{"issue":"1","key":"177_CR95","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0301-2115(03)00081-2","volume":"110","author":"K Duric","year":"2003","unstructured":"Duric K, Skrablin S, Lesin J, Kalafatic D, Kuvacic I, Suchanek E: Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol. 2003, 110 (1): 12-15. 10.1016\/S0301-2115(03)00081-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"177_CR96","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1067\/S0002-9378(03)00655-0","volume":"189","author":"LK Endres","year":"2003","unstructured":"Endres LK, Krotz S, Grobman WA: Isolated low second-trimester maternal serum beta-human chorionic gonadotropin is not associated with adverse pregnancy outcome. Am J Obstet Gynecol. 2003, 189 (3): 755-757. 10.1067\/S0002-9378(03)00655-0.","journal-title":"Am J Obstet Gynecol"},{"issue":"6429","key":"177_CR97","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/bmj.288.6429.1494","volume":"288","author":"J Evans","year":"1984","unstructured":"Evans J, Stokes IM: Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha fetoprotein concentrations. Br Med J (Clin Res Ed). 1984, 288 (6429): 1494-","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"177_CR98","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/pd.1970060202","volume":"6","author":"A Ghosh","year":"1986","unstructured":"Ghosh A, Tang MH, Tai D, Nie G, Ma HK: Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects. Prenat Diagn. 1986, 6 (2): 83-87. 10.1002\/pd.1970060202.","journal-title":"Prenat Diagn"},{"issue":"1","key":"177_CR99","first-page":"83","volume":"80","author":"R Gonen","year":"1992","unstructured":"Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 1992, 80 (1): 83-86.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR100","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0002-9378(79)90064-4","volume":"133","author":"YB Gordon","year":"1979","unstructured":"Gordon YB, Lewis JD, Leighton M, Kitau MJ, Clarke PC, Chard T: Maternal serum alpha-fetoprotein levels as an index of fetal risk. Am J Obstet Gynecol. 1979, 133 (4): 422-424.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"177_CR101","first-page":"556","volume":"62","author":"JE Haddow","year":"1983","unstructured":"Haddow JE, Kloza EM, Smith DE, Knight GJ: Data from an alpha-fetoprotein pilot screening program in Maine. Obstet Gynecol. 1983, 62 (5): 556-60.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"177_CR102","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-0528.1986.tb07959.x","volume":"93","author":"JE Haddow","year":"1986","unstructured":"Haddow JE, Knight GJ, Kloza EM, Palomaki GE: Alpha-fetoprotein, vaginal bleeding and pregnancy risk. Br J Obstet Gynaecol. 1986, 93 (6): 589-593.","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"177_CR103","first-page":"26","volume":"70","author":"JE Haddow","year":"1987","unstructured":"Haddow JE, Palomaki GE, Knight GJ: Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?. Obstet Gynecol. 1987, 70 (1): 26-28.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR104","first-page":"465","volume":"65","author":"MP Hamilton","year":"1985","unstructured":"Hamilton MP, Abdalla HI, Whitfield CR: Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses. Obstet Gynecol. 1985, 65 (4): 465-470.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"177_CR105","first-page":"1211","volume":"44","author":"M Hayashi","year":"1992","unstructured":"Hayashi M, Kohzu H: [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases \u2013 the median value, pregnancy outcomes and clinical evaluation]. Nippon Sanka Fujinka Gakkai Zasshi. 1992, 44 (10): 1211-1218.","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"1","key":"177_CR106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10641950109152646","volume":"20","author":"A Heikkila","year":"2001","unstructured":"Heikkila A, Makkonen N, Heinonen S, Kirkinen P: Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies. Hypertens Pregnancy. 2001, 20 (1): 99-106.","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"177_CR107","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2105\/AJPH.89.4.561","volume":"89","author":"S Heinonen","year":"1999","unstructured":"Heinonen S, Ryynanen M, Kirkinen P: The effects on fetal development of high alpha-fetoprotein and maternal smoking. Am J Public Health. 1999, 89 (4): 561-563.","journal-title":"Am J Public Health"},{"issue":"(1)2","key":"177_CR108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1034\/j.1600-0412.2003.820104.x","volume":"8","author":"R Hershkovitz","year":"2003","unstructured":"Hershkovitz R, Erez O, Sheiner E, Landau D, Mankuta D, Mazor M: Elevated maternal mid-trimester chorionic gonadotropin > or = 4 MoM is associated with fetal cerebral blood flow redistribution. Acta Obstet Gynecol Scand. 2003, 8 ((1)2): 22-27. 10.1034\/j.1600-0412.2003.820104.x.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"177_CR109","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1515\/JPM.2006.026","volume":"34","author":"ZN Kavak","year":"2006","unstructured":"Kavak ZN, Basgul A, Elter K, Uygur M, Gokaslan H: The efficacy of first-trimester PAPP-A and free betahCG levels for predicting adverse pregnancy outcome. J Perinat Med. 2006, 34 (2): 145-148. 10.1515\/JPM.2006.026.","journal-title":"J Perinat Med"},{"issue":"2","key":"177_CR110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3349\/ymj.2000.41.2.226","volume":"41","author":"SY Kim","year":"2000","unstructured":"Kim SY, Kim SK, Lee JS, Kim IK, Lee K: The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome. Yonsei Med J. 2000, 41 (2): 226-229.","journal-title":"Yonsei Med J"},{"issue":"3","key":"177_CR111","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01443610500060693","volume":"25","author":"TS Kiran","year":"2005","unstructured":"Kiran TS, Bethel J, Bhal PS: Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome. J Obstet Gynaecol. 2005, 25 (3): 253-256. 10.1080\/01443610500060693.","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"177_CR112","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ajog.2004.05.068","volume":"191","author":"D Krantz","year":"2004","unstructured":"Krantz D, Goetzl L, Simpson JL, Thom E, Zachery J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group: Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004, 191 (4): 1452-1458. 10.1016\/j.ajog.2004.05.068.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"177_CR113","first-page":"319","volume":"102","author":"PL Kuo","year":"2003","unstructured":"Kuo PL, Lin CC, Lin YH, Guo HR: Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels. J Formos Med Assoc. 2003, 102 (5): 319-325.","journal-title":"J Formos Med Assoc"},{"issue":"6","key":"177_CR114","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.0004-8666.2003.00126.x","volume":"43","author":"M Kwik","year":"2003","unstructured":"Kwik M, Morris J: Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol. 2003, 43 (6): 438-442. 10.1046\/j.0004-8666.2003.00126.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"177_CR115","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1479-828X.1985.tb00741.x","volume":"25","author":"M Legge","year":"1985","unstructured":"Legge M, Duff GB, Pike L, Aickin DR: Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk. Aust N Z J Obstet Gynaecol. 1985, 25 (4): 266-268. 10.1111\/j.1479-828X.1985.tb00741.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"177_CR116","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1067\/mob.2003.278","volume":"188","author":"N Lepage","year":"2003","unstructured":"Lepage N, Chitayat D, Kingdom J, Huang T: Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol. 2003, 188 (5): 1354-1359. 10.1067\/mob.2003.278.","journal-title":"Am J Obstet Gynecol"},{"issue":"6 Pt 1","key":"177_CR117","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/0002-9378(93)90701-J","volume":"168","author":"RE Lieppman","year":"1993","unstructured":"Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA: An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol. 1993, 168 (6 Pt 1): 1852-1856.","journal-title":"Am J Obstet Gynecol"},{"key":"177_CR118","first-page":"50","volume":"165","author":"T Markestad","year":"1997","unstructured":"Markestad T, Bergsjo P, Aakvaag A, Lie RT, Jacobsen G, Hoffman HJ, Bakketeig LS: Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. Acta Obstet Gynecol Scand Suppl. 1997, 165: 50-55.","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"4","key":"177_CR119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000264310","volume":"11","author":"A Milunsky","year":"1996","unstructured":"Milunsky A, Nebiolo L: Maternal serum triple analyte screening and adverse pregnancy outcome. Fetal Diagn Ther. 1996, 11 (4): 249-253.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"177_CR120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000053879","volume":"16","author":"K Miyakoshi","year":"2001","unstructured":"Miyakoshi K, Tanaka M, Gabionza D, Ishimoto H, Miyazaki T, Yoshimura Y: Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study. Fetal Diagn Ther. 2001, 16 (1): 42-46. 10.1159\/000053879.","journal-title":"Fetal Diagn Ther"},{"issue":"11","key":"177_CR121","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/pd.1970151109","volume":"15","author":"LP Morssink","year":"1995","unstructured":"Morssink LP, Kornman LH, Beekhuis JR, De Wolf BT, Mantingh A: Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery. Prenat Diagn. 1995, 15 (11): 1041-1046. 10.1002\/pd.1970151109.","journal-title":"Prenat Diagn"},{"issue":"3","key":"177_CR122","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00016348509155128","volume":"64","author":"FT Mwambingu","year":"1985","unstructured":"Mwambingu FT: Association between unaccountably high maternal alpha feto-protein and increased fetal risk. Acta Obstet Gynecol Scand. 1985, 64 (3): 275-276.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"177_CR123","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/714052710","volume":"10","author":"CS Naylor","year":"2001","unstructured":"Naylor CS, Porto M, Cohen B, Garite TJ: Pregnancy outcome in Hispanic patients with unexplained positive triple marker screening for Down syndrome. J Matern Fetal Med. 2001, 10 (1): 20-22. 10.1080\/714052710.","journal-title":"J Matern Fetal Med"},{"issue":"6","key":"177_CR124","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1055\/s-2006-947724","volume":"23","author":"AO Odibo","year":"2006","unstructured":"Odibo AO, Sehdev HM, Stamilio DM, Macones GA: Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Am J Perinatol. 2006, 23 (6): 363-7. 10.1055\/s-2006-947724.","journal-title":"Am J Perinatol"},{"issue":"2","key":"177_CR125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/(SICI)1097-0223(200002)20:2<96::AID-PD766>3.0.CO;2-#","volume":"20","author":"R Ogle","year":"2000","unstructured":"Ogle R, Jauniaux E, Pahal GS, Dell E, Sheldrake A, Rodeck C: Serum screening for Down syndrome and adverse pregnancy outcomes: a case-controlled study. Prenat Diagn. 2000, 20 (2): 96-99. 10.1002\/(SICI)1097-0223(200002)20:2<96::AID-PD766>3.0.CO;2-#.","journal-title":"Prenat Diagn"},{"issue":"2","key":"177_CR126","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0029-7844(95)00108-4","volume":"86","author":"E Pergament","year":"1995","unstructured":"Pergament E, Stein AK, Fiddler M, Cho NH, Kupferminc MJ: Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol. 1995, 86 (2): 255-258. 10.1016\/0029-7844(95)00108-4.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"177_CR127","first-page":"779","volume":"40","author":"AP Roop","year":"1991","unstructured":"Roop AP, Boughman JA, Blitzer MG: Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome. Maryland Medical Journal. 1991, 40 (9): 779-784.","journal-title":"Maryland Medical Journal"},{"issue":"2","key":"177_CR128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-2007-999919","volume":"2","author":"NJ Secher","year":"1985","unstructured":"Secher NJ, Eriksen PS, Hansen PK, Lenstrup C, Thisted J: High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age. Am J Perinatol. 1985, 2 (2): 78-81.","journal-title":"Am J Perinatol"},{"issue":"1","key":"177_CR129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000191302.79560.d8","volume":"107","author":"GC Smith","year":"2006","unstructured":"Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM, Cameron AD, Connor MJ, Dobbie R: Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol. 2006, 107 (1): 161-6.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"177_CR130","first-page":"449","volume":"88","author":"S Sritippayawan","year":"2005","unstructured":"Sritippayawan S, Vachirasrisoontra C: Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. J Med Assoc Thai. 2005, 88 (4): 449-454.","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"177_CR131","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0029-7844(03)00235-7","volume":"101","author":"AM Summers","year":"2003","unstructured":"Summers AM, Huang T, Meier C, Wyatt PR: The implications of a false positive second-trimester serum screen for Down syndrome. Obstet Gynecol. 2003, 101 (6): 1301-1306. 10.1016\/S0029-7844(03)00235-7.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"177_CR132","first-page":"1229","volume":"46","author":"M Tanaka","year":"1994","unstructured":"Tanaka M, Natori M, Ishimoto , Gohda N, Kiyokawa K, Yamauchi J, Miyazaki T, Kpbayashi T, Nozawa S: [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin]. Nippon Sanka Fujinka Gakkai Zasshi. 1994, 46 (11): 1229-1233.","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"issue":"6","key":"177_CR133","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.ajog.2006.03.011","volume":"194","author":"D Towner","year":"2006","unstructured":"Towner D, Gandhi S, El KD: Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. Am J Obstet Gynecol. 2006, 194 (6): 1676-81. 10.1016\/j.ajog.2006.03.011.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"177_CR134","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/pd.735","volume":"23","author":"N Tul","year":"2003","unstructured":"Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z: Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A. Prenat Diagn. 2003, 23 (12): 990-996. 10.1002\/pd.735.","journal-title":"Prenat Diagn"},{"issue":"8032","key":"177_CR135","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(77)90953-9","volume":"2","author":"N Wald","year":"1977","unstructured":"Wald N, Cuckle H, Stirrat GM, Bennett MJ, Turnbull AC: Maternal serum-alpha-fetoprotein and low birth-weight. Lancet. 1977, 2 (8032): 268-270. 10.1016\/S0140-6736(77)90953-9.","journal-title":"Lancet"},{"issue":"10","key":"177_CR136","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-0528.1980.tb04437.x","volume":"87","author":"NJ Wald","year":"1980","unstructured":"Wald NJ, Cuckle HS, Boreham J, Turnbull AC: Maternal serum alpha-fetoprotein and birth weight. Br J Obstet Gynaecol. 1980, 87 (10): 860-863.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"177_CR137","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2007-999393","volume":"8","author":"CP Weiner","year":"1991","unstructured":"Weiner CP, Grant SS, Williamson RA: Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery. Am J Perinatol. 1991, 8 (4): 263-268.","journal-title":"Am J Perinatol"},{"issue":"6","key":"177_CR138","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0002-9378(92)91733-Q","volume":"167","author":"KD Wenstrom","year":"1992","unstructured":"Wenstrom KD, Sipes SL, Williamson RA, Grant SS, Trawick DC, Estle LC: Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests. Am J Obstet Gynecol. 1992, 167 (6): 1529-1533.","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"177_CR139","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1471-0528.1984.tb04740.x","volume":"91","author":"JG Westergaard","year":"1984","unstructured":"Westergaard JG, Teisner B, Hau J, Grudzinskas JG: Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation. Br J Obstet Gynaecol. 1984, 91 (12): 1216-1223.","journal-title":"Br J Obstet Gynaecol"},{"issue":"4 Pt 1","key":"177_CR140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0002-9378(12)80033-0","volume":"167","author":"MA Williams","year":"1992","unstructured":"Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, Mahon BS: Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992, 167 (4 Pt 1): 1032-1037.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"177_CR141","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/(SICI)1520-6661(199811\/12)7:6<304::AID-MFM9>3.0.CO;2-4","volume":"7","author":"SJ Zarzour","year":"1998","unstructured":"Zarzour SJ, Gabert HA, Diket AL, St AM, Miller JM: Abnormal maternal serum alpha fetoprotein and pregnancy outcome. J Matern Fetal Med. 1998, 7 (6): 304-307. 10.1002\/(SICI)1520-6661(199811\/12)7:6<304::AID-MFM9>3.0.CO;2-4.","journal-title":"J Matern Fetal Med"},{"issue":"15","key":"177_CR142","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Beccker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283 (15): 2008-2012. 10.1001\/jama.283.15.2008.","journal-title":"JAMA"},{"issue":"6","key":"177_CR143","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","volume":"104","author":"A Conde-Agudelo","year":"2004","unstructured":"Conde-Agudelo A, Villar J, Lindheimer M: World health organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004, 104 (6): 1367-1391.","journal-title":"Obstet Gynecol"},{"issue":"5 Pt 1","key":"177_CR144","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.AOG.0000162539.68541.c2","volume":"105","author":"JC Cnossen","year":"2005","unstructured":"Cnossen JC, Mol BW, Post van der JAM, Bossuyt PM, ter Riet G: World health organization systematic review of screening tests for pre-eclampsia. Obstet Gynecol. 2005, 105 (5 Pt 1): 1151-1152.","journal-title":"Obstet Gynecol"},{"key":"177_CR145","volume-title":"Stat Med","author":"AH Zwinderman","year":"2007","unstructured":"Zwinderman AH, Bossuyt PM: We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med. 2007."},{"issue":"10","key":"177_CR146","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH: Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005, 58 (10): 982-990. 10.1016\/j.jclinepi.2005.02.022.","journal-title":"J Clin Epidemiol"},{"key":"177_CR147","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2288-5-19","volume":"5","author":"P Whiting","year":"2005","unstructured":"Whiting P, Harbord R, Kleijnen J: No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol. 2005, 5: 19-10.1186\/1471-2288-5-19.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"177_CR148","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1479-828X.2000.tb01137.x","volume":"40","author":"MA Brown","year":"2000","unstructured":"Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters NJ: The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol. 2000, 40 (2): 139-155. 10.1111\/j.1479-828X.2000.tb01137.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8995","key":"177_CR149","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0140-6736(96)90338-4","volume":"347","author":"A Shennan","year":"1996","unstructured":"Shennan A, Gupta M, Halligan A, Taylor DJ, de Swiet M: Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996, 347 (8995): 139-142. 10.1016\/S0140-6736(96)90338-4.","journal-title":"Lancet"},{"issue":"3","key":"177_CR150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0002-9378(94)90079-5","volume":"171","author":"MA Brown","year":"1994","unstructured":"Brown MA, Reiter L, Smith B, Buddle ML, Morris R, Whitworth JA: Measuring blood pressure in pregnant women: A comparison of direct and indirect methods. Am J Obstet Gynecol. 1994, 171 (3): 661-667.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"177_CR151","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0306-5456(00)00205-9","volume":"108","author":"B Clausson","year":"2001","unstructured":"Clausson B, Gardosi J, Francis A, Cnattingius S: Perinatal outcome in SGA births defined by customised versus population based birthweight standards. BJOG. 2001, 108 (8): 830-834. 10.1016\/S0306-5456(00)00205-9.","journal-title":"BJOG"},{"issue":"7","key":"177_CR152","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0002-9378(66)90033-0","volume":"94","author":"K Scott","year":"1986","unstructured":"Scott K, Usher R: Fetal malnutrition: its incidence, causes and effects. Am J Obstet Gynecol. 1986, 94 (7): 951-963.","journal-title":"Am J Obstet Gynecol"},{"issue":"7458","key":"177_CR153","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","volume":"329","author":"J Deeks","year":"2004","unstructured":"Deeks J, Altman D: Diagnostic tests: Likelihood ratios. BMJ. 2004, 329 (7458): 168-169. 10.1136\/bmj.329.7458.168.","journal-title":"BMJ"},{"issue":"4","key":"177_CR154","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/0002-9378(95)91336-X","volume":"173","author":"PS Konchak","year":"1995","unstructured":"Konchak PS, Bernstein IM, Capeless EL: Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol. 1995, 173 (4): 1115-1119. 10.1016\/0002-9378(95)91336-X.","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-8-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-8-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-8-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:44:31Z","timestamp":1709167471000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-8-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,4]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-8-33","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,4]]},"article-number":"33"}}